Recent Company News

• 09:21 PM ET Feb 24, 2026
  

  NICE recommends Genentech's Avastin (and biosimilars) with fluoropyrimidine-based chemotherapy to treat metastatic colorectal cancer (CHF 374.00, 0.00)

• 05:01 PM ET Jan 12, 2026
  

  StreetAccount Sector Summary - Healthcare Post-Market

• 12:10 PM ET Feb 24, 2026
  

  StreetAccount Consensus Metrics Preview - BeOne Medicines Q4 Earnings ($370.64, 0.00)

• 08:01 PM ET Feb 20, 2026
  

  StreetAccount Sector Summary - Healthcare Weekly Recap

• 01:03 AM ET Feb 04, 2026
  

  StreetAccount Sector Summary - China Healthcare January Recap

• 08:55 AM ET Jan 13, 2026
  

  StreetAccount Sector Summary - Healthcare Pre-Market

• 11:23 AM ET Jan 13, 2026
  

  Transcript Intelligence: BeOne Medicines at J.P. Morgan Healthcare Conference ($344.30, +10.31)

• 06:03 AM ET Jan 13, 2026
  

  BeOne Medicines outlines presentations for today's Annual J.P. Morgan Healthcare Conference ($333.99, 0.00)